JCEM2 Best of JCEM 2015 Part II

Program: Special Scientific Session
Clinical Session
Sunday, April 3, 2016: 4:45 PM-6:45 PM
Room 107 (BCEC)
Chair:
R. Paul Robertson, MD, Univ of Washington, Seattle, WA

Nothing to Disclose: RPR

4:50 PM
Catherine Calzada, PhD, Cardiovasculaire, Métabolisme, Diabétologie and Nutrition, Inserm UMR 1060/Université de Lyon, Villeurbanne, France
Nothing to Disclose: CC
5:10 PM
Giulia Rastrelli, MD, PhD, Department of Experimental Clinical and Biomedical Sciences, University of Florence, Florence, ITALY
Nothing to Disclose: GR
5:30 PM
José-Manuel Fernandez-Real, MD, PhD, Section of Diabetes, Endocrinology and Nutrition, Hospital of Girona, Girona, Spain
Nothing to Disclose: JMF
5:50 PM
Basil Rapoport, Thyroid Autoimmune Disease Unit, Cedara-Sinai Medical Center, West Hollywood, CA
Nothing to Disclose: BR

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire